1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Liu, Q. Moldoveanu, T. Sprules, T. Matta-Camacho, E. Mansur-Azzam, N. Gehring, K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 285 19615 19624 10.1074/jbc.M110.105452 20392693 Apoptotic regulation by MCL-1 through heterodimerization. 2010 10.2210/pdb2kbw/pdb pdb_00002kbw 18716.164 Induced myeloid leukemia cell differentiation protein Mcl-1 residues 167-326 1 man polymer 3733.175 BH3-interacting domain death agonist BH3 motif, residues 76-106 1 man polymer Bcl-2-related protein EAT/mcl1, mcl1/EAT p22 BID, BID, BH3-interacting domain death agonist p15, p15 BID, BH3-interacting domain death agonist p13, p13 BID, BH3-interacting domain death agonist p11, p11 BID no no TPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDD VKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVE DLEG TPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDD VKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVE DLEG A polypeptide(L) no no GPLGSESQEDIIRNIARHLAQVGDSMDRSIPPGLV GPLGSESQEDIIRNIARHLAQVGDSMDRSIPPGLV B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample MCL1, Myeloid Cell Leukemia 1 9606 Homo sapiens 562 Escherichia coli BL21 pET32a human sample BID 9606 Homo sapiens 562 Escherichia coli BL21 pGEX-6p1 database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Data collection Database references Derived calculations 1 0 2009-12-15 1 1 2011-07-13 1 2 2022-03-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model solution structure of free Mcl-1 BMRB Y RCSB 2008-12-09 REL REL 2934 973 386 631 747 190 0 0 141 141 structures with the lowest energy 200 10 2D 1H-15N HSQC 2D 1H-15N HSQC 2D 1H-15N HSQC 2D 1H-15N HSQC 2D 1H-15N HSQC 3D CBCA(CO)NH 3D HNCO 3D HNCA 3D HNCACB 3D 1H-15N NOESY 2D 1H-15N HSQC 3D CBCA(CO)NH 3D HNCACB 3D HNCO 3D HNCA 3D 1H-15N NOESY 2D 1H-15N HSQC 2D 1H-13C HSQC 3D HCCH-COSY 3D 1H-13C NOESY 2D 1H-13C HSQC 3D HCCH-COSY 3D 1H-13C NOESY 3D CCH-TOCSY 3D 1H-15N NOESY N15C13 filtered 3D 1H-13C NOESY N15C13 filtered 3D 1H-15N NOESY N15C13 filtered 3D 1H-13C NOESY N15C13 filtered 3D 1H-15N heteronuclear NOESY 3D 1H-15N heteronuclear NOESY IPAP-HSQC IPAP-HSQC IPAP-HSQC IPAP-HSQC 0.5 mM [U-95% 15N] 0.5 mM 20 mM 1 mM 0.5 mM 0.5 mM [U-95% 15N] 20 mM 1 mM 0.5 mM [U-95% 13C; U-95% 15N] 0.5 mM 20 mM 1 mM 0.5 mM [U-95% 13C; U-95% 15N] 0.5 mM 20 mM 1 mM 100 % [U-100% 2H] 0.5 mM 0.5 mM [U-95% 13C; U-95% 15N] 20 mM 1 mM 0.5 mM 0.5 mM [U-95% 13C; U-95% 15N] 20 mM 1 mM 100 % [U-100% 2H] 0.4 mM [U-95% 15N] 0.4 mM 20 mM 1 mM 6 mg/mL 0.4 mM 0.4 mM [U-95% 15N] 20 mM 1 mM 8 mg/mL 20 6.5 ambient 303 K simulated annealing 1 lowest energy 0.5 mM [U-95% 15N] Mcl-1-1, 0.5 mM Bid_BH3-2, 20 mM HEPES-3, 1 mM DTT-4, 90% H2O/10% D2O 90% H2O/10% D2O 0.5 mM Mcl-1-5, 0.5 mM [U-95% 15N] Bid_BH3-6, 20 mM HEPES-7, 1 mM DTT-8, 90% H2O/10% D2O 90% H2O/10% D2O 0.5 mM [U-95% 13C; U-95% 15N] Mcl-1-9, 0.5 mM Bid_BH3-10, 20 mM HEPES-11, 1 mM DTT-12, 90% H2O/10% D2O 90% H2O/10% D2O 0.5 mM [U-95% 13C; U-95% 15N] Mcl-1-13, 0.5 mM Bid_BH3-14, 20 mM HEPES-15, 1 mM DTT-16, 100 % [U-100% 2H] D2O-17, 100% D2O 100% D2O 0.5 mM Mcl-1-18, 0.5 mM [U-95% 13C; U-95% 15N] Bid_BH3-19, 20 mM HEPES-20, 1 mM DTT-21, 90% H2O/10% D2O 90% H2O/10% D2O 0.5 mM Mcl-1-22, 0.5 mM [U-95% 13C; U-95% 15N] Bid_BH3-23, 20 mM HEPES-24, 1 mM DTT-25, 100 % [U-100% 2H] D2O-26, 100% D2O 100% D2O 0.4 mM [U-95% 15N] Mcl-1-27, 0.4 mM Bid_BH3-28, 20 mM HEPES-29, 1 mM DTT-30, 6 mg/mL Pf1 phage-31, 90% H2O/10% D2O 90% H2O/10% D2O 0.4 mM Mcl-1-32, 0.4 mM [U-95% 15N] Bid_BH3-33, 20 mM HEPES-34, 1 mM DTT-35, 8 mg/mL Pf1 phage-36, 90% H2O/10% D2O 90% H2O/10% D2O Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRDraw Bruker Biospin collection XwinNMR Bruker Biospin processing XwinNMR Varian collection VnmrJ Johnson, One Moon Scientific data analysis NMRView Cornilescu, Delaglio and Bax data analysis TALOS Guntert, Mumenthaler and Wuthrich structure solution CYANA Brunger, Adams, Clore, Gros, Nilges and Read refinement CNS Laskowski and MacArthur data analysis ProcheckNMR 800 Varian INOVA Varian INOVA 600 Bruker AVANCE Bruker Avance 500 Varian INOVA Varian INOVA n 1 163 A n 2 164 A n 3 165 A n 4 166 A ALA 167 n 5 ALA 167 A GLU 168 n 6 GLU 168 A GLU 169 n 7 GLU 169 A GLU 170 n 8 GLU 170 A GLU 171 n 9 GLU 171 A ASP 172 n 10 ASP 172 A GLU 173 n 11 GLU 173 A LEU 174 n 12 LEU 174 A TYR 175 n 13 TYR 175 A ARG 176 n 14 ARG 176 A GLN 177 n 15 GLN 177 A SER 178 n 16 SER 178 A LEU 179 n 17 LEU 179 A GLU 180 n 18 GLU 180 A ILE 181 n 19 ILE 181 A ILE 182 n 20 ILE 182 A SER 183 n 21 SER 183 A ARG 184 n 22 ARG 184 A TYR 185 n 23 TYR 185 A LEU 186 n 24 LEU 186 A ARG 187 n 25 ARG 187 A GLU 188 n 26 GLU 188 A GLN 189 n 27 GLN 189 A ALA 190 n 28 ALA 190 A THR 191 n 29 THR 191 A GLY 192 n 30 GLY 192 A ALA 193 n 31 ALA 193 A LYS 194 n 32 LYS 194 A ASP 195 n 33 ASP 195 A THR 196 n 34 THR 196 A LYS 197 n 35 LYS 197 A PRO 198 n 36 PRO 198 A MET 199 n 37 MET 199 A GLY 200 n 38 GLY 200 A ARG 201 n 39 ARG 201 A SER 202 n 40 SER 202 A GLY 203 n 41 GLY 203 A ALA 204 n 42 ALA 204 A THR 205 n 43 THR 205 A SER 206 n 44 SER 206 A ARG 207 n 45 ARG 207 A LYS 208 n 46 LYS 208 A ALA 209 n 47 ALA 209 A LEU 210 n 48 LEU 210 A GLU 211 n 49 GLU 211 A THR 212 n 50 THR 212 A LEU 213 n 51 LEU 213 A ARG 214 n 52 ARG 214 A ARG 215 n 53 ARG 215 A VAL 216 n 54 VAL 216 A GLY 217 n 55 GLY 217 A ASP 218 n 56 ASP 218 A GLY 219 n 57 GLY 219 A VAL 220 n 58 VAL 220 A GLN 221 n 59 GLN 221 A ARG 222 n 60 ARG 222 A ASN 223 n 61 ASN 223 A HIS 224 n 62 HIS 224 A GLU 225 n 63 GLU 225 A THR 226 n 64 THR 226 A ALA 227 n 65 ALA 227 A PHE 228 n 66 PHE 228 A GLN 229 n 67 GLN 229 A GLY 230 n 68 GLY 230 A MET 231 n 69 MET 231 A LEU 232 n 70 LEU 232 A ARG 233 n 71 ARG 233 A LYS 234 n 72 LYS 234 A LEU 235 n 73 LEU 235 A ASP 236 n 74 ASP 236 A ILE 237 n 75 ILE 237 A LYS 238 n 76 LYS 238 A ASN 239 n 77 ASN 239 A GLU 240 n 78 GLU 240 A ASP 241 n 79 ASP 241 A ASP 242 n 80 ASP 242 A VAL 243 n 81 VAL 243 A LYS 244 n 82 LYS 244 A SER 245 n 83 SER 245 A LEU 246 n 84 LEU 246 A SER 247 n 85 SER 247 A ARG 248 n 86 ARG 248 A VAL 249 n 87 VAL 249 A MET 250 n 88 MET 250 A ILE 251 n 89 ILE 251 A HIS 252 n 90 HIS 252 A VAL 253 n 91 VAL 253 A PHE 254 n 92 PHE 254 A SER 255 n 93 SER 255 A ASP 256 n 94 ASP 256 A GLY 257 n 95 GLY 257 A VAL 258 n 96 VAL 258 A THR 259 n 97 THR 259 A ASN 260 n 98 ASN 260 A TRP 261 n 99 TRP 261 A GLY 262 n 100 GLY 262 A ARG 263 n 101 ARG 263 A ILE 264 n 102 ILE 264 A VAL 265 n 103 VAL 265 A THR 266 n 104 THR 266 A LEU 267 n 105 LEU 267 A ILE 268 n 106 ILE 268 A SER 269 n 107 SER 269 A PHE 270 n 108 PHE 270 A GLY 271 n 109 GLY 271 A ALA 272 n 110 ALA 272 A PHE 273 n 111 PHE 273 A VAL 274 n 112 VAL 274 A ALA 275 n 113 ALA 275 A LYS 276 n 114 LYS 276 A HIS 277 n 115 HIS 277 A LEU 278 n 116 LEU 278 A LYS 279 n 117 LYS 279 A THR 280 n 118 THR 280 A ILE 281 n 119 ILE 281 A ASN 282 n 120 ASN 282 A GLN 283 n 121 GLN 283 A GLU 284 n 122 GLU 284 A SER 285 n 123 SER 285 A CYS 286 n 124 CYS 286 A ILE 287 n 125 ILE 287 A GLU 288 n 126 GLU 288 A PRO 289 n 127 PRO 289 A LEU 290 n 128 LEU 290 A ALA 291 n 129 ALA 291 A GLU 292 n 130 GLU 292 A SER 293 n 131 SER 293 A ILE 294 n 132 ILE 294 A THR 295 n 133 THR 295 A ASP 296 n 134 ASP 296 A VAL 297 n 135 VAL 297 A LEU 298 n 136 LEU 298 A VAL 299 n 137 VAL 299 A ARG 300 n 138 ARG 300 A THR 301 n 139 THR 301 A LYS 302 n 140 LYS 302 A ARG 303 n 141 ARG 303 A ASP 304 n 142 ASP 304 A TRP 305 n 143 TRP 305 A LEU 306 n 144 LEU 306 A VAL 307 n 145 VAL 307 A LYS 308 n 146 LYS 308 A GLN 309 n 147 GLN 309 A ARG 310 n 148 ARG 310 A GLY 311 n 149 GLY 311 A TRP 312 n 150 TRP 312 A ASP 313 n 151 ASP 313 A GLY 314 n 152 GLY 314 A PHE 315 n 153 PHE 315 A VAL 316 n 154 VAL 316 A GLU 317 n 155 GLU 317 A PHE 318 n 156 PHE 318 A PHE 319 n 157 PHE 319 A HIS 320 n 158 HIS 320 A VAL 321 n 159 VAL 321 A GLU 322 n 160 GLU 322 A ASP 323 n 161 ASP 323 A LEU 324 n 162 LEU 324 A GLU 325 n 163 GLU 325 A GLY 326 n 164 GLY 326 A n 1 72 B n 2 73 B n 3 74 B n 4 75 B SER 76 n 5 SER 76 B GLU 77 n 6 GLU 77 B SER 78 n 7 SER 78 B GLN 79 n 8 GLN 79 B GLU 80 n 9 GLU 80 B ASP 81 n 10 ASP 81 B ILE 82 n 11 ILE 82 B ILE 83 n 12 ILE 83 B ARG 84 n 13 ARG 84 B ASN 85 n 14 ASN 85 B ILE 86 n 15 ILE 86 B ALA 87 n 16 ALA 87 B ARG 88 n 17 ARG 88 B HIS 89 n 18 HIS 89 B LEU 90 n 19 LEU 90 B ALA 91 n 20 ALA 91 B GLN 92 n 21 GLN 92 B VAL 93 n 22 VAL 93 B GLY 94 n 23 GLY 94 B ASP 95 n 24 ASP 95 B SER 96 n 25 SER 96 B MET 97 n 26 MET 97 B ASP 98 n 27 ASP 98 B ARG 99 n 28 ARG 99 B SER 100 n 29 SER 100 B ILE 101 n 30 ILE 101 B PRO 102 n 31 PRO 102 B PRO 103 n 32 PRO 103 B GLY 104 n 33 GLY 104 B LEU 105 n 34 LEU 105 B VAL 106 n 35 VAL 106 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A THR 163 A THR 1 1 Y 1 A PRO 164 A PRO 2 1 Y 1 A PRO 165 A PRO 3 1 Y 1 A PRO 166 A PRO 4 1 Y 1 B GLY 72 B GLY 1 1 Y 1 B PRO 73 B PRO 2 1 Y 1 B LEU 74 B LEU 3 1 Y 1 B GLY 75 B GLY 4 1 Y 2 A THR 163 A THR 1 1 Y 2 A PRO 164 A PRO 2 1 Y 2 A PRO 165 A PRO 3 1 Y 2 A PRO 166 A PRO 4 1 Y 2 B GLY 72 B GLY 1 1 Y 2 B PRO 73 B PRO 2 1 Y 2 B LEU 74 B LEU 3 1 Y 2 B GLY 75 B GLY 4 1 Y 3 A THR 163 A THR 1 1 Y 3 A PRO 164 A PRO 2 1 Y 3 A PRO 165 A PRO 3 1 Y 3 A PRO 166 A PRO 4 1 Y 3 B GLY 72 B GLY 1 1 Y 3 B PRO 73 B PRO 2 1 Y 3 B LEU 74 B LEU 3 1 Y 3 B GLY 75 B GLY 4 1 Y 4 A THR 163 A THR 1 1 Y 4 A PRO 164 A PRO 2 1 Y 4 A PRO 165 A PRO 3 1 Y 4 A PRO 166 A PRO 4 1 Y 4 B GLY 72 B GLY 1 1 Y 4 B PRO 73 B PRO 2 1 Y 4 B LEU 74 B LEU 3 1 Y 4 B GLY 75 B GLY 4 1 Y 5 A THR 163 A THR 1 1 Y 5 A PRO 164 A PRO 2 1 Y 5 A PRO 165 A PRO 3 1 Y 5 A PRO 166 A PRO 4 1 Y 5 B GLY 72 B GLY 1 1 Y 5 B PRO 73 B PRO 2 1 Y 5 B LEU 74 B LEU 3 1 Y 5 B GLY 75 B GLY 4 1 Y 6 A THR 163 A THR 1 1 Y 6 A PRO 164 A PRO 2 1 Y 6 A PRO 165 A PRO 3 1 Y 6 A PRO 166 A PRO 4 1 Y 6 B GLY 72 B GLY 1 1 Y 6 B PRO 73 B PRO 2 1 Y 6 B LEU 74 B LEU 3 1 Y 6 B GLY 75 B GLY 4 1 Y 7 A THR 163 A THR 1 1 Y 7 A PRO 164 A PRO 2 1 Y 7 A PRO 165 A PRO 3 1 Y 7 A PRO 166 A PRO 4 1 Y 7 B GLY 72 B GLY 1 1 Y 7 B PRO 73 B PRO 2 1 Y 7 B LEU 74 B LEU 3 1 Y 7 B GLY 75 B GLY 4 1 Y 8 A THR 163 A THR 1 1 Y 8 A PRO 164 A PRO 2 1 Y 8 A PRO 165 A PRO 3 1 Y 8 A PRO 166 A PRO 4 1 Y 8 B GLY 72 B GLY 1 1 Y 8 B PRO 73 B PRO 2 1 Y 8 B LEU 74 B LEU 3 1 Y 8 B GLY 75 B GLY 4 1 Y 9 A THR 163 A THR 1 1 Y 9 A PRO 164 A PRO 2 1 Y 9 A PRO 165 A PRO 3 1 Y 9 A PRO 166 A PRO 4 1 Y 9 B GLY 72 B GLY 1 1 Y 9 B PRO 73 B PRO 2 1 Y 9 B LEU 74 B LEU 3 1 Y 9 B GLY 75 B GLY 4 1 Y 10 A THR 163 A THR 1 1 Y 10 A PRO 164 A PRO 2 1 Y 10 A PRO 165 A PRO 3 1 Y 10 A PRO 166 A PRO 4 1 Y 10 B GLY 72 B GLY 1 1 Y 10 B PRO 73 B PRO 2 1 Y 10 B LEU 74 B LEU 3 1 Y 10 B GLY 75 B GLY 4 1 Y 1 A GLU 170 -179.24 -37.05 1 A ASP 195 -115.16 62.48 1 A THR 196 -104.07 71.02 1 A SER 202 -166.68 -60.27 1 A LEU 235 -57.59 -70.34 1 A ASP 236 56.82 109.33 1 A LYS 238 -144.58 -3.50 1 A ARG 310 82.15 -23.93 1 A HIS 320 63.97 125.78 1 B GLU 77 52.43 154.02 1 B GLN 79 -39.73 -38.79 1 B SER 100 -167.40 92.12 2 A GLU 168 -144.99 -66.96 2 A LYS 194 19.48 84.85 2 A LYS 197 42.31 81.44 2 A PRO 198 -50.42 -74.10 2 A MET 199 -77.51 -169.16 2 A GLU 225 -36.66 -39.32 2 A LEU 235 -58.59 -70.86 2 A ASP 236 59.79 112.08 2 A LYS 238 179.78 -27.14 2 A GLN 283 -144.01 58.92 2 A ARG 310 75.49 -17.26 2 A HIS 320 66.28 -74.69 2 A LEU 324 52.63 176.66 2 A GLU 325 55.40 102.62 2 B GLU 77 -127.46 -156.02 2 B SER 100 -177.13 41.68 2 B PRO 103 -75.18 -169.87 3 A GLU 171 -53.04 -76.01 3 A ARG 201 -152.93 -82.06 3 A SER 202 56.12 95.76 3 A LEU 235 -58.10 -70.53 3 A ASP 236 59.49 112.25 3 A LYS 238 -141.63 -9.92 3 A GLN 283 -143.85 44.76 3 A ARG 310 78.44 -25.45 3 A ASP 323 -149.06 31.71 3 A GLU 325 -100.95 -62.48 3 B GLU 77 -133.83 -156.92 3 B SER 100 -176.16 85.06 3 B PRO 103 -67.10 60.63 4 A GLU 168 68.91 -66.26 4 A GLU 169 -56.94 177.49 4 A LYS 194 -67.97 74.44 4 A SER 202 -170.46 66.62 4 A LEU 235 -56.83 -70.67 4 A ASP 236 58.04 109.64 4 A LYS 238 174.53 -28.84 4 A ASN 282 88.96 62.98 4 A GLN 283 -142.60 47.57 4 A ARG 310 85.02 -22.31 4 A HIS 320 -138.38 -141.22 4 A ASP 323 -177.13 38.10 4 B GLU 77 -130.65 -155.29 4 B SER 100 179.69 83.92 4 B PRO 103 -66.63 60.58 5 A GLU 170 178.86 -35.82 5 A LYS 194 -67.40 76.88 5 A PRO 198 -46.23 167.40 5 A ARG 201 -157.13 26.92 5 A LEU 235 -57.36 -71.14 5 A ASP 236 60.12 112.51 5 A LYS 238 179.08 -28.86 5 A ARG 310 87.90 -32.34 5 A GLU 322 -91.48 48.39 5 B GLU 77 -130.37 -155.49 5 B SER 100 -177.25 96.82 6 A GLU 168 -140.22 -56.97 6 A ASP 172 -62.26 83.82 6 A THR 196 82.35 -24.33 6 A LYS 197 38.37 81.42 6 A PRO 198 -53.43 -74.75 6 A SER 202 79.21 178.48 6 A ASP 236 57.17 112.04 6 A LYS 238 171.83 54.66 6 A GLN 283 -141.08 52.12 6 A ARG 310 80.43 -18.56 6 A ASP 323 -149.05 50.72 6 A LEU 324 -126.27 -65.79 6 B SER 100 -170.94 94.83 6 B PRO 103 -66.00 61.01 6 B LEU 105 51.09 89.59 7 A GLU 169 -81.28 -75.56 7 A LYS 194 -46.67 89.97 7 A THR 196 -93.28 46.56 7 A MET 199 71.05 -62.81 7 A ASP 236 102.02 -76.23 7 A ILE 237 54.08 155.69 7 A LYS 238 149.72 -16.31 7 A GLN 283 -150.66 58.91 7 A GLN 309 -96.26 34.47 7 A GLU 325 60.95 95.15 7 B GLU 77 -129.79 -155.18 7 B SER 78 -165.71 116.90 7 B ARG 99 -93.88 36.15 7 B SER 100 -178.08 63.79 8 A GLU 170 64.15 133.76 8 A GLU 171 -158.49 -69.86 8 A ALA 193 -154.77 85.65 8 A LYS 194 -81.44 -151.92 8 A THR 196 -142.49 -37.22 8 A PRO 198 -62.48 83.20 8 A MET 199 72.62 -164.82 8 A ARG 201 -162.75 -78.74 8 A SER 202 -166.28 -164.21 8 A LEU 235 -55.28 -71.03 8 A ASP 236 60.10 111.91 8 A LYS 238 179.31 -27.79 8 A GLU 240 -49.65 -18.30 8 A ARG 310 79.88 -22.90 8 B GLU 77 -131.44 -156.35 8 B SER 78 -168.35 116.80 8 B SER 100 -155.67 39.14 8 B LEU 105 -152.17 41.40 9 A GLU 170 -178.38 -63.96 9 A ASP 195 -54.95 104.67 9 A PRO 198 -57.47 -156.43 9 A LEU 235 -56.51 -71.89 9 A ASP 236 57.83 105.88 9 A LYS 238 -151.70 4.68 9 A HIS 320 62.57 125.47 9 A LEU 324 43.54 -165.41 9 B GLU 77 61.41 155.54 9 B SER 100 -177.40 89.43 10 A GLU 168 42.81 88.85 10 A PRO 198 -57.31 -171.91 10 A MET 199 -174.97 -37.77 10 A ARG 201 57.40 92.90 10 A LEU 235 -55.17 -71.30 10 A ASP 236 59.00 111.11 10 A LYS 238 -145.15 -9.90 10 A GLN 283 -151.47 69.06 10 A HIS 320 -93.29 54.50 10 A GLU 325 60.66 104.78 10 B SER 100 -171.65 94.03 lowest energy, model 1 Solution Structure of human Mcl-1 complexed with human Bid_BH3 peptide 1 N N 2 N N A ASP 172 A ASP 10 HELX_P A GLY 192 A GLY 30 1 1 21 A GLY 203 A GLY 41 HELX_P A HIS 224 A HIS 62 1 2 22 A HIS 224 A HIS 62 HELX_P A ASP 236 A ASP 74 1 3 13 A ASN 239 A ASN 77 HELX_P A ASP 241 A ASP 79 5 4 3 A ASP 242 A ASP 80 HELX_P A SER 255 A SER 93 1 5 14 A ASN 260 A ASN 98 HELX_P A ILE 281 A ILE 119 1 6 22 A CYS 286 A CYS 124 HELX_P A LYS 302 A LYS 140 1 7 17 A LYS 302 A LYS 140 HELX_P A GLN 309 A GLN 147 1 8 8 A TRP 312 A TRP 150 HELX_P A HIS 320 A HIS 158 1 9 9 B SER 78 B SER 7 HELX_P B SER 100 B SER 29 1 10 23 APOPTOSIS Mcl-1, Bid_BH3, complex, Alternative splicing, Apoptosis, Cytoplasm, Developmental protein, Differentiation, Membrane, Mitochondrion, Nucleus, Phosphoprotein, Polymorphism, Transmembrane, Ubl conjugation MCL1_HUMAN UNP 1 163 Q07820 TPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDD VKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVE DLEG BID_HUMAN UNP 2 76 P55957 SESQEDIIRNIARHLAQVGDSMDRSIPPGLV 163 326 2KBW 163 326 Q07820 A 1 1 164 76 106 2KBW 76 106 P55957 B 2 5 35 1 P 1